|1 Table of Contents 3
|1.1 List of Tables 5
|1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, France 10
3.1 Drug Delivery Devices Market, France, Revenue ($m), 2018-2033 10
3.2 Drug Delivery Devices Market, France, Revenue Mix ($m), 2023 11
3.3 Drug Delivery Devices Market, France, Category Contribution by Revenue ($m), 2023 12
3.4 Drug Delivery Devices Market, France, Revenue ($m), 2018-2033 13
3.5 Drug Delivery Devices Market, France, Volume (Units), 2018-2033 15
3.6 Drug Delivery Devices Market, France, Volume (Units), 2018-2033 16
3.7 Drug Delivery Devices Market, France, Company Share by Revenue ($m), 2023 18
4 Central Venous Catheters Market, France 20
4.1 Central Venous Catheters Market, France, Revenue Mix ($m), 2023 20
4.2 Central Venous Catheters Market, France, Segment Contribution (%), 2023 21
4.3 Central Venous Catheters Market, France, Revenue ($m), 2018-2033 22
4.4 Central Venous Catheters Market, France, Volume (Units), 2018-2033 24
4.5 Central Venous Catheters Market, France, Average Price ($) , 2018-2033 26
4.6 Central Venous Catheters Market, France, Distribution Share by Revenue ($m), 2023 27
4.7 Central Venous Catheters Market, France, Company Share by Revenue ($m), 2023 28
5 Implantable Ports Market, France 30
5.1 Implantable Ports Market, France, Revenue Mix ($m), 2023 30
5.2 Implantable Ports Market, France, Segment Contribution (%), 2023 31
5.3 Implantable Ports Market, France, Revenue ($m), 2018-2033 32
5.4 Implantable Ports Market, France, Volume (Units), 2018-2033 34
5.5 Implantable Ports Market, France, Average Price ($) , 2018-2033 36
5.6 Implantable Ports Market, France, Distribution Share by Revenue ($m), 2023 37
5.7 Implantable Ports Market, France, Company Share by Revenue ($m), 2023 38
6 Infusion Systems Market, France 39
6.1 Infusion Systems Market, France, Revenue Mix ($m), 2023 39
6.2 Infusion Systems Market, France, Segment Contribution (%), 2023 40
6.3 Infusion Systems Market, France, Revenue ($m), 2018-2033 41
6.3.1 Infusion Pump Disposables Market, France, Revenue ($m), by Segment, 2018-2033 43
6.3.2 Infusion Pumps Market, France, Revenue ($m), by Segment, 2018-2033 45
6.4 Infusion Systems Market, France, Volume (Units), 2018-2033 46
6.4.1 Infusion Pump Disposables Market, France, Volume (Units), by Segment, 2018-2033 48
6.4.2 Infusion Pumps Market, France, Volume (Units), by Segment, 2018-2033 50
6.5 Infusion Systems Market, France, Average Price ($), 2018-2033 51
6.6 Infusion Systems Market, France, Distribution Share by Revenue ($m), 2023 52
6.7 Infusion Systems Market, France, Company Share by Revenue ($m), 2023 53
7 Overview of Key Companies in France, Drug Delivery Devices Market 54
7.1 B. Braun Melsungen AG 54
7.1.1 Company Overview 54
7.2 Becton Dickinson and Co 54
7.2.1 Company Overview 54
7.3 Teleflex Inc 54
7.3.1 Company Overview 54
7.4 Vygon SA 54
7.4.1 Company Overview 54
7.5 Edwards Lifesciences Corp 55
7.5.1 Company Overview 55
7.6 Baxter International Inc 55
7.6.1 Company Overview 55
7.7 ICU Medical Inc 55
7.7.1 Company Overview 55
8 Drug Delivery Devices Market Pipeline Products 56
9 Financial Deals Landscape 64
9.1 Equity Offerings 64
9.1.1 Crossject Raises USD8.57 Million in Rights Offering of Shares 64
10 Recent Developments 66
10.1 Financial Announcements 66
10.1.1 Mar 13, 2025: Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update 66
10.1.2 Mar 06, 2025: EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 69
10.1.3 Dec 23, 2024: Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update 69
10.1.4 Aug 06, 2024: Cellectis Provides Financial Results for the Second Quarter 2024 70
10.2 Government and Public Interest 71
10.2.1 Sep 03, 2024: Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference 71
10.2.2 Jul 15, 2024: Crossject to Attend H.C. Wainwright 26th Annual Global Investment Conference 72
10.3 Other Significant Developments 72
10.3.1 Feb 06, 2025: Completion of the Transactions Announced in December 2024 Relating to the Amendment of the Convertible Bonds Subscribed by an Entity Affiliated to Heights Capital Management and the Issue of a Second Assimilable Tranche 72
10.3.2 Jan 13, 2025: EDAP Announces Preliminary Record Fourth Quarter Focal One System Sales and Record U.S. Procedures 75
10.4 Product News 75
10.4.1 Oct 04, 2024: Published Research Study : “Development of a New Method for Analyzing the Behavior of Rapidly Dissolving Films in Contact with Liquids” 75
11 Appendix 76
11.1 Research Methodology 77
11.1.1 Coverage 77
11.1.2 Secondary Research 77
11.1.3 Primary Research 78
11.1.4 Market Modeling and Forecasting 79
11.1.5 Company Share Analysis 80
11.1.6 Distribution Share Analysis 80
11.1.7 Benchmarking 81
11.2 GlobalData Consulting 81
11.3 Contact Us 81
11.4 Disclaimer 82